Harrison.Ai Raises Aud$129 Million And Partners With Sonic Healthcare To Develop Pathology Ai, Accelerating Its Mission To Expand Capacity Of Global Healthcare
Harrison.Ai Raises Aud$129 Million And Partners With Sonic Healthcare To Develop Pathology Ai, Accelerating Its Mission To Expand Capacity Of Global Healthcare
12/01/21, 12:01 AM
Location
sydneyMoney raised
$129 million
Harrison.ai, the breakthrough healthcare AI company, today announced it has raised AU$129 million (USD$97 million) in one of Australia's largest-ever Series B funding rounds. The funding will go to helping Harrison.ai expand on its mission to scale critical capacity in the global healthcare system through rapid commercialisation of comprehensive clinical AI applications.
Company Info
Location
sydney, new south wales, australia
Additional Info
Harrison.ai is a clinician-led healthcare artificial intelligence (AI) company rapidly developing and deploying AI solutions to address persistent healthcare challenges. With a mission to make world-class healthcare available and affordable to all, Harrison.ai works closely with clinical partners to deliver clinical-grade AI software at scale.
Harrison.ai works with partners to develop and deploy AI healthcare solutions that impact 50,000 patients each month in Australia, Europe and other countries. These include working with Virtus Health Limited to develop AI in IVF, as well as I-MED on Annalise CXR, the world's most comprehensive AI clinical decision-support solution for chest X-rays. In July 2021, a Annalise CXR validation study published in the Lancet Digital Health found the AI model was capable of identifying 124 findings on chest x-rays to support and improve radiologist findings.